Hans Eriksson, MD
- 6Articles
- 44.4KReads
- 2011–2019Active
- 32Collaborators
- 372Citations
About
Hans Eriksson, MD, has contributed to research on major depressive disorder, schizophrenia, schizoaffective disorders, suicide, and weight-related metabolic changes. His publications include clinical studies evaluating adjunctive brexpiprazole and quetiapine fumarate treatments, focusing on efficacy, safety, and tolerability in patients with inadequate response to antidepressants or persistent symptoms. Eriksson has also examined the reliability and validity of assessment tools such as the Sheehan Irritability Scale. His work was published between 2011 and 2019 in Psychiatrist.com journals.
Publications
Brexpiprazole in MDD—Metabolic Parameters and Weight
October 1, 2019
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
